Advertisement
Australia markets closed
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • AUD/USD

    0.6615
    +0.0043 (+0.66%)
     
  • OIL

    78.02
    -0.93 (-1.18%)
     
  • GOLD

    2,305.20
    -4.40 (-0.19%)
     
  • Bitcoin AUD

    93,261.26
    +3,802.51 (+4.25%)
     
  • CMC Crypto 200

    1,339.01
    +62.04 (+4.86%)
     
  • AUD/EUR

    0.6141
    +0.0021 (+0.34%)
     
  • AUD/NZD

    1.0991
    -0.0018 (-0.16%)
     
  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     
  • NASDAQ

    17,901.55
    +360.01 (+2.05%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • Dow Jones

    38,675.32
    +449.66 (+1.18%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

New Strong Sell Stocks for April 22nd

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

AMN Healthcare Services, Inc. AMN is a healthcare workforce solutions and staffing services company. The Zacks Consensus Estimate for its current year earnings has been revised 9.4% downward over the last 60 days.

PROG Holdings, Inc. PRG is a fin-tech company that provides payment options. The Zacks Consensus Estimate for its current year earnings has been revised 12.9% downward over the last 60 days.

Arcadia Biosciences, Inc. RKDA is a manufacturer of plant-based health and wellness products. The Zacks Consensus Estimate for its current year earnings has been revised 1.8% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AMN Healthcare Services Inc (AMN) : Free Stock Analysis Report

Arcadia Biosciences, Inc. (RKDA) : Free Stock Analysis Report

Aaron's Holdings Company, Inc. (PRG) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research